menu
    • menu

    Company profile for OBiO Technology

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2013 and headquartered in Shanghai, OBiO is a biotechnology company focusing on gene and cell therapy field: serving as a contract research organization for vectorology and functional genomics studies and providing contract development and manufacturing services of IND-enabling CMC, clinical and commercial manufacturing. In recent years, in line with the mission of enabling gene therapy for better lives, OBiO has es...
    Founded in 2013 and headquartered in Shanghai, OBiO is a biotechnology company focusing on gene and cell therapy field: serving as a contract research organization for vectorology and functional genomics studies and providing contract development and manufacturing services of IND-enabling CMC, clinical and commercial manufacturing. In recent years, in line with the mission of enabling gene therapy for better lives, OBiO has established core technologies around vectorology development, large-scale process development and manufacturing, facilitating a robust and versatile GMP manufacturing system for various gene and cell therapy products.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    OBiO TechnologyChina Flag
    Country
    Country
    China
    Address
    Address
    Building No.19, Lane 908, Ziping Rd, Pudong New District, Shanghai
    Telephone
    Telephone
    +86 400-151-5198
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.obio-tech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/obiotech/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    OBiO Supports First Clinical Gene Editing By CorrectSequence
    OBiO Supports First Clinical Gene Editing By CorrectSequence

    06 Aug 2024

    // PRESS RELEASE

    https://www.biospace.com/obio-technology-congratulates-on-the-first-clinical-gene-editing-therapy-to-treat-an-overseas-patient-in-china-by-correctsequence-therapeutics

    PRESS RELEASE
    06 Aug 2024
    Share Share
    Three Benefits Of Partnering With A CDMO For Cell And Gene Therapy Manufacturing
    Three Benefits Of Partnering With A CDMO For Cell And Gene Therapy Manufacturing

    15 Jun 2024

    // PRESS RELEASE

    https://www.obio-tech.com/news-details/releases/21

    PRESS RELEASE
    15 Jun 2024
    Share Share
    OBiO Launches Pediatric Rare Disease Advanced Therapy Translation Center
    OBiO Launches Pediatric Rare Disease Advanced Therapy Translation Center

    30 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/obio-technology-officially-launched-the-center-for-clinical-evaluation-and-translation-of-advanced-therapies-for-pediatric-rare-and-genetic-diseases-302158742.html

    PR NEWSWIRE
    30 May 2024
    Share Share
    Meet OBiO Technology at ASGCT 2024! May 7th to 11th
    Meet OBiO Technology at ASGCT 2024! May 7th to 11th

    27 Apr 2024

    // PRESS RELEASE

    https://www.obio-tech.com/news-details/releases/20

    PRESS RELEASE
    27 Apr 2024
    Share Share
    The 2024 Cell and Gene Therapy Workshop,
    The 2024 Cell and Gene Therapy Workshop, "Horizons Unveiled

    03 Apr 2024

    // PRESS RELEASE

    https://www.obio-tech.com/news-details/releases/18

    PRESS RELEASE
    03 Apr 2024
    Share Share
    Dynamic Partnership Between OBiO Technology
    Dynamic Partnership Between OBiO Technology

    03 Apr 2024

    // PRESS RELEASE

    https://www.obio-tech.com/news-details/releases/19

    PRESS RELEASE
    03 Apr 2024
    Share Share

    ABOUT THIS PAGE

    Contact OBiO Technology and get a quotation

    OBiO Technology is a supplier offers 5 products (APIs, Excipients or Intermediates).

    Find D02 PLASMID bulk offered by OBiO Technology

    Find D08 PLASMID bulk offered by OBiO Technology

    Find D03 PLASMID bulk offered by OBiO Technology

    Find D04 PLASMID bulk offered by OBiO Technology

    Find D01 PLASMID bulk offered by OBiO Technology

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search